HIV Vaccine Market has been segmented on the basis of type which comprises of acute paronychia, chronic paronychia, candidal paronychia and pyogenic paronychia. On the basis of antibiotics, market is segmented into mupirocin ointment, fusidic acid ointment, gentamicin ointment, dicloxacillin and others.
This report contains market size and forecasts of HIV Vaccines in Global, including the following market information:
- Global HIV Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global HIV Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Phase I Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of HIV Vaccines include Argos Therapeutics, Bionor Pharma, Janssen Global Services, Genecure, Geovax, Paxvax, Inovio Pharmaceuticals, Glaxosmithkline and Sanofi. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the HIV Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global HIV Vaccines Market Segment Percentages, by Type, 2021 (%)
- Phase I
- Phase II
- Phase III
Global HIV Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global HIV Vaccines Market Segment Percentages, by Application, 2021 (%)
- Research Institute
- Others
Global HIV Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global HIV Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies HIV Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies HIV Vaccines revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Argos Therapeutics
- Bionor Pharma
- Janssen Global Services
- Genecure
- Geovax
- Paxvax
- Inovio Pharmaceuticals
- Glaxosmithkline
- Sanofi
